beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy
- PMID: 9724301
- DOI: 10.1152/ajpheart.1998.275.3.H961
beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy
Abstract
To establish whether catecholamines per se in the absence of significant increases in systolic load induce myocardial damage via apoptosis, rats were treated with vehicle or isoproterenol (400 microg . kg-1 . h-1). Apoptotic cardiocytes (Apo) were identified in paraffin-embedded sections using terminal deoxynucleotide transferase-mediated dUTP nick end labeling. Results were confirmed using an independent ligase assay. Systolic blood pressures were comparable in isoproterenol-treated and control rats. Twenty-four hours of treatment with isoproterenol resulted in significant numbers of Apo compared with control [7.9 +/- 2.5 vs. 0.3 +/- 0.3 (SE) cm-2, P < 0.05]. A cohort of animals was subjected to ventricular pacing to induce a tachycardia equivalent to that induced by isoproterenol, and these animals did not show an increase in Apo. The left ventricular hypertrophy induced by 2 wk of abdominal aortic banding also increased Apo ( approximately 7. 2-fold); however, 24 h of isoproterenol infusion did not induce additional Apo in these rats. Thus catecholamines, in the absence of altered systolic load, induce Apo which is not mediated solely by tachycardia. Left ventricular hypertrophy secondary to abdominal aortic banding is associated with Apo, but this does not increase sensitivity to isoproterenol-induced Apo.
Similar articles
-
Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats.Can J Physiol Pharmacol. 2000 Mar;78(3):260-5. Can J Physiol Pharmacol. 2000. PMID: 10721819
-
Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.Circ Res. 2003 Jul 11;93(1):12-22. doi: 10.1161/01.RES.0000079794.57578.F1. Epub 2003 Jun 5. Circ Res. 2003. PMID: 12791704
-
Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.Cardioscience. 1995 Mar;6(1):47-57. Cardioscience. 1995. PMID: 7605896
-
Bromocriptine-induced tachycardia in conscious rats: blunted response following isoproterenol pretreatment for 5 days.Acta Physiol Pharmacol Ther Latinoam. 1998;48(3):165-74. Acta Physiol Pharmacol Ther Latinoam. 1998. PMID: 9777039
-
Adrenergic overload and apoptosis in heart failure: implications for therapy.J Card Fail. 2000 Jun;6(2 Suppl 1):1-7. J Card Fail. 2000. PMID: 10908092 Review.
Cited by
-
Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study.Heart Rhythm. 2011 Jan;8(1):84-90. doi: 10.1016/j.hrthm.2010.10.023. Epub 2010 Oct 20. Heart Rhythm. 2011. PMID: 20970524 Free PMC article.
-
Cardiomyocyte life-death decisions in response to chronic β-adrenergic signaling.Circ Res. 2013 Feb 1;112(3):408-10. doi: 10.1161/CIRCRESAHA.113.300805. Circ Res. 2013. PMID: 23371896 Free PMC article. No abstract available.
-
Cardiac GPCRs: GPCR signaling in healthy and failing hearts.Biochim Biophys Acta. 2007 Apr;1768(4):1006-18. doi: 10.1016/j.bbamem.2007.02.010. Epub 2007 Feb 20. Biochim Biophys Acta. 2007. PMID: 17376402 Free PMC article. Review.
-
NF2 signaling pathway plays a pro-apoptotic role in β-adrenergic receptor stimulated cardiac myocyte apoptosis.PLoS One. 2018 Apr 30;13(4):e0196626. doi: 10.1371/journal.pone.0196626. eCollection 2018. PLoS One. 2018. PMID: 29709009 Free PMC article.
-
New medical therapies for heart failure.Nat Rev Cardiol. 2015 Dec;12(12):730-40. doi: 10.1038/nrcardio.2015.137. Epub 2015 Sep 29. Nat Rev Cardiol. 2015. PMID: 26416006 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources